Analyst Ratings For NYSE:MD – Mednax (NYSE:MD)
Today, Credit Suisse Group lowered its price target on NYSE:MD – Mednax (NYSE:MD) to per share.
Some recent analyst ratings include
- 2/9/2018-Mizuho Reiterated Rating of Neutral ➝ Neutral.
Recent Insider Trading Activity For NYSE:MD – Mednax (NYSE:MD)
NYSE:MD – Mednax (NYSE:MD) has insider ownership of 2.70% and institutional ownership of 98.53%.
- On 3/13/2018 John C Pepia, Insider, sold 3,000 with an average share price of $58.35 per share and the total transaction amounting to $175,050.00.
- On 12/12/2017 John C Pepia, Insider, sold 3,000 with an average share price of $51.58 per share and the total transaction amounting to $154,740.00.
- On 11/3/2017 Cesar L Alvarez, Director, sold 10,668 with an average share price of $42.59 per share and the total transaction amounting to $454,350.12.
- On 9/12/2017 John C Pepia, Insider, sold 3,000 with an average share price of $42.85 per share and the total transaction amounting to $128,550.00.
- On 6/14/2017 Md Pascal J Goldschmidt, Director, sold 1,969 with an average share price of $57.57 per share and the total transaction amounting to $113,355.33.
- On 6/1/2017 Joseph M Calabro, Insider, sold 23,327 with an average share price of $55.00 per share and the total transaction amounting to $1,282,985.00.
- On 5/5/2017 Manuel Kadre, Director, bought 21,704 with an average share price of $55.79 per share and the total transaction amounting to $1,210,866.16.
Recent Trading Activity for NYSE:MD – Mednax (NYSE:MD)
Shares of NYSE:MD – Mednax closed the previous trading session at 45.59 up +0.34 0.75% with 46.0 shares trading hands.